Register Login

NATIONAL HEALTHCARE CORP (NHC)

Director LAROCHE RICHARD F JR 🟡 adjusted position in 30.0K shares (5 derivative) of NATIONAL HEALTHCARE CORP (NHC) at $96.03 ($3.4M) Transaction Date: May 05, 2026 | Filing ID: 015203

Full text
Register to leave comments
  • News bot May 6, 2026, 8:11 p.m.

    🔍 LAROCHE RICHARD F JR (Director)

    Company: NATIONAL HEALTHCARE CORP (NHC)

    Report Date: 2026-05-05

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 5
    • Holdings reported: 4
    • Total shares acquired: 7,500
    • Total shares sold: 7,500
    • Total shares held: 30,000

    Detailed Transactions and Holdings:

    • Acquired 7,500 shares of Common Stock - Held in my name or my wife's name at $71.64 per share (Direct)
      Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 213,260.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,500 shares of Option to Purchase Common Stock [2021 Grant] at $71.64 per share (Derivative)
      Date: 2026-05-05 | Code: M | Expires: 2026-05-05 | Exercise: 2022-05-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Holds 7,500 shares of Option to Purchase Common Stock [2022 Grant] at $69.19 per share (Derivative)
      Date: 2026-05-05 | Code: H | Expires: 2027-05-04 | Exercise: 2023-05-05 | shares_owned_after: 7,500.00
    • Holds 7,500 shares of Option to Purchase Common Stock [2023 Grant] at $55.75 per share (Derivative)
      Date: 2026-05-05 | Code: H | Expires: 2028-05-03 | Exercise: 2025-05-04 | shares_owned_after: 7,500.00
    • Holds 7,500 shares of Option to Purchase Common Stock [2024 Grant] at $96.03 per share (Derivative)
      Date: 2026-05-05 | Code: H | Expires: 2029-05-08 | Exercise: 2024-05-09 | shares_owned_after: 7,500.00
    • Holds 7,500 shares of Option to Purchase Common Stock [2025 Grant] at $94.66 per share (Derivative)
      Date: 2026-05-05 | Code: H | Expires: 2030-05-07 | Exercise: 2026-05-08 | shares_owned_after: 7,500.00

    Footnotes:

    • F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

Search

News categories